Pages that link to "Q249978"
Jump to navigation
Jump to search
The following pages link to Eva Klein (Q249978):
Displaying 50 items.
- George Klein (Q513281) (← links)
- SH2D1A expression reflects activation of T and NK cells in cord blood lymphocytes infected with EBV and treated with the immunomodulator PSK (Q28216084) (← links)
- Putative association between a new polymorphism in exon 3 (Arg109Cys) of the pancreatic colipase gene and type 2 diabetes mellitus in two independent Caucasian study populations (Q28274411) (← links)
- Two new Loci for body-weight regulation identified in a joint analysis of genome-wide association studies for early-onset extreme obesity in French and german study groups (Q28943490) (← links)
- Lack of association between the tagging SNP A+930-->G of SOCS3 and type 2 diabetes mellitus: meta-analysis of four independent study populations (Q33389180) (← links)
- IL-21 imposes a type II EBV gene expression on type III and type I B cells by the repression of C- and activation of LMP-1-promoter (Q33640213) (← links)
- The MEC1 and MEC2 lines represent two CLL subclones in different stages of progression towards prolymphocytic leukemia (Q34097631) (← links)
- Type I interferons directly down-regulate BCL-6 in primary and transformed germinal center B cells: differential regulation in B cell lines derived from endemic or sporadic Burkitt's lymphoma (Q34113234) (← links)
- Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution (Q34142739) (← links)
- Latency type-dependent modulation of Epstein-Barr virus-encoded latent membrane protein 1 expression by type I interferons in B cells (Q34161866) (← links)
- Heterogeneity of the Stearoyl-CoA desaturase-1 (SCD1) gene and metabolic risk factors in the EPIC-Potsdam study (Q34471950) (← links)
- Microsomal triglyceride transfer protein -164 T > C gene polymorphism and risk of cardiovascular disease: results from the EPIC-Potsdam case-cohort study (Q34565383) (← links)
- Association of prostaglandin E synthase 2 (PTGES2) Arg298His polymorphism with type 2 diabetes in two German study populations (Q34637050) (← links)
- Polymorphisms within insulin-degrading enzyme (IDE) gene determine insulin metabolism and risk of type 2 diabetes (Q34659248) (← links)
- Soluble factors produced by activated CD4+ T cells modulate EBV latency (Q35749824) (← links)
- Surveillance against tumors--is it mainly immunological? (Q36243808) (← links)
- Cytokine mediated induction of the major Epstein-Barr virus (EBV)-encoded transforming protein, LMP-1. (Q36357129) (← links)
- The proapoptotic function of SAP provides a clue to the clinical picture of X-linked lymphoproliferative disease (Q37274351) (← links)
- A polymorphism within the connective tissue growth factor (CTGF) gene has no effect on non-invasive markers of beta-cell area and risk of type 2 diabetes (Q37306046) (← links)
- Meta-analysis of the INSIG2 association with obesity including 74,345 individuals: does heterogeneity of estimates relate to study design? (Q37377502) (← links)
- Large-scale hypomethylated blocks associated with Epstein-Barr virus-induced B-cell immortalization (Q37550182) (← links)
- To the genesis of Burkitt lymphoma: regulation of apoptosis by EBNA-1 and SAP may determine the fate of Ig-myc translocation carrying B lymphocytes (Q37624012) (← links)
- Deficiency of the proapoptotic SAP function in X-linked lymphoproliferative disease aggravates Epstein-Barr virus (EBV) induced mononucleosis and promotes lymphoma development (Q37676572) (← links)
- Interaction of Epstein-Barr virus (EBV) with human B-lymphocytes (Q37759796) (← links)
- Restricted expression of EBV encoded proteins in in vitro infected CLL cells (Q37804964) (← links)
- T cells modulate Epstein-Barr virus latency phenotypes during infection of humanized mice (Q38326876) (← links)
- The role of DNA hypomethylation, histone acetylation and in vivo protein-DNA binding in Epstein-Barr virus-induced CD23 upregulation (Q39167067) (← links)
- Simultaneous detection of the two main proliferation driving EBV encoded proteins, EBNA-2 and LMP-1 in single B cells (Q39291434) (← links)
- STAT6 signaling pathway activated by the cytokines IL-4 and IL-13 induces expression of the Epstein-Barr virus–encoded protein LMP-1 in absence of EBNA-2: implications for the type II EBV latent gene expression in Hodgkin lymphoma (Q39650776) (← links)
- Concomitant increase of LMP1 and CD25 (IL-2-receptor alpha) expression induced by IL-10 in the EBV-positive NK lines SNK6 and KAI3. (Q40225147) (← links)
- IL-10 can induce the expression of EBV-encoded latent membrane protein-1 (LMP-1) in the absence of EBNA-2 in B lymphocytes and in Burkitt lymphoma- and NK lymphoma-derived cell lines (Q40342745) (← links)
- EBV infection induces expression of the transcription factors ATF-2/c-Jun in B lymphocytes but not in B-CLL cells (Q40435330) (← links)
- In vitro EBV-infected subline of KMH2, derived from Hodgkin lymphoma, expresses only EBNA-1, while CD40 ligand and IL-4 induce LMP-1 but not EBNA-2. (Q40498343) (← links)
- Upregulation of LMP1 expression by histone deacetylase inhibitors in an EBV carrying NPC cell line (Q40596404) (← links)
- cMyc-p53 feedback mechanism regulates the dynamics of T lymphocytes in the immune response (Q41878064) (← links)
- Cytomegalovirus-seropositive children show inhibition of in vitro EBV infection that is associated with CD8+CD57+ T cell enrichment and IFN-γ. (Q42261208) (← links)
- p53 contributes to T cell homeostasis through the induction of pro-apoptotic SAP. (Q43130273) (← links)
- Evidence for the Thr79Met polymorphism of the ileal fatty acid binding protein (FABP6) to be associated with type 2 diabetes in obese individuals (Q43278361) (← links)
- Vitamin D receptor and calcium sensing receptor polymorphisms and the risk of colorectal cancer in European populations (Q43286228) (← links)
- Association of the FTO rs9939609 single nucleotide polymorphism with C-reactive protein levels (Q43566803) (← links)
- Polymorphisms of genes coding for ghrelin and its receptor in relation to anthropometry, circulating levels of IGF-I and IGFBP-3, and breast cancer risk: a case-control study nested within the European Prospective Investigation into Cancer and Nutri (Q43885695) (← links)
- Monocytes enhance cell proliferation and LMP1 expression of nasal natural killer/T-cell lymphoma cells by cell contact-dependent interaction through membrane-bound IL-15. (Q43920073) (← links)
- The X-linked lymphoproliferative disease gene product SAP is expressed in activated T and NK cells. (Q43991331) (← links)
- Association of acyl-CoA-binding protein (ACBP) single nucleotide polymorphisms and type 2 diabetes in two German study populations (Q44471824) (← links)
- Body mass index and C-174G interleukin-6 promoter polymorphism interact in predicting type 2 diabetes (Q44835076) (← links)
- Genetic variation in genes of the fatty acid synthesis pathway and breast cancer risk (Q46104145) (← links)
- SH2D1A expression in Burkitt lymphoma cells is restricted to EBV positive group I lines and is downregulated in parallel with immunoblastic transformation (Q48628470) (← links)
- L-FABP T94A is associated with fasting triglycerides and LDL-cholesterol in women. (Q51471819) (← links)
- PSK and Trx80 inhibit B-cell growth in EBV-infected cord blood mononuclear cells through T cells activated by the monocyte products IL-15 and IL-12. (Q51593404) (← links)
- Interferon γ is a strong, STAT1-dependent direct inducer of BCL6 expression in multiple myeloma cells. (Q52728538) (← links)